Therefore, we tested the hypothesis that elevated levels of FOXP3 immunostaining in primary tumors and regional lymph nodes would predict the presence of lymph node metastases in pancreatic cancer. The gene discussed is FOXP3; the disease is pancreatic neoplasm.